BE728658A - - Google Patents
Info
- Publication number
- BE728658A BE728658A BE728658DA BE728658A BE 728658 A BE728658 A BE 728658A BE 728658D A BE728658D A BE 728658DA BE 728658 A BE728658 A BE 728658A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB00906/68A GB1203691A (en) | 1968-03-06 | 1968-03-06 | New disubstituted n-amino indoline derivatives and process for preparing them |
Publications (1)
Publication Number | Publication Date |
---|---|
BE728658A true BE728658A (e) | 1969-08-19 |
Family
ID=9976474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE728658D BE728658A (e) | 1968-03-06 | 1969-02-19 |
Country Status (13)
Country | Link |
---|---|
US (1) | US3565911A (e) |
BE (1) | BE728658A (e) |
CH (1) | CH507940A (e) |
DE (1) | DE1909180A1 (e) |
DK (1) | DK126193B (e) |
ES (1) | ES364421A1 (e) |
FI (1) | FI50119C (e) |
FR (1) | FR2003311A1 (e) |
GB (1) | GB1203691A (e) |
IT (1) | IT8049196A0 (e) |
NL (1) | NL145226B (e) |
NO (1) | NO128068B (e) |
SE (1) | SE334887B (e) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4112111A (en) * | 1975-02-26 | 1978-09-05 | Sandoz Ltd. | Indolinylguanidines |
IT1113879B (it) * | 1979-03-15 | 1986-01-27 | Farmatis Spa | Derivato isoindolinico,processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo |
LU82949A1 (fr) * | 1980-11-20 | 1981-06-04 | Usv Pharma Corp | Nouveaux amino-benzamides,leur procede de preparation et leur application au traitement de l'hypertension |
DE3172386D1 (en) * | 1980-12-22 | 1985-10-24 | Usv Pharma Corp | Synthesis of indolines |
JPS57206657A (en) * | 1981-06-16 | 1982-12-18 | Mitsui Toatsu Chem Inc | Sulfamoylbenzoic acid derivative and remedying composition containing said derivative as active component |
FR2529785A1 (fr) * | 1982-07-09 | 1984-01-13 | Adir | Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne |
FR2663324B1 (fr) * | 1990-06-14 | 1992-09-04 | Adir | Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide. |
FR2663325B1 (fr) * | 1990-06-14 | 1992-09-04 | Adir | Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide a partir de la 2,3-dihydro 2-methyl 1h-indole et de l'acide hydroxylamine-o-sulfonique. |
FR2677886B1 (fr) * | 1991-06-18 | 1995-03-31 | Adir | Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale. |
US5319096A (en) * | 1992-04-03 | 1994-06-07 | Hoechst-Roussel Pharmaceuticals Inc. | (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use |
IT1288123B1 (it) * | 1996-09-04 | 1998-09-10 | Nicox Sa | Uso di nitroderivati per l'incontinenza urinaria |
AP2005003232A0 (en) | 2002-08-19 | 2005-03-31 | Pfizer Prod Inc | Combination therapy for hyperproliferative diseases. |
US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
JP2008520578A (ja) * | 2004-11-15 | 2008-06-19 | ニトロメッド インコーポレーティッド | 複素環式の酸化窒素供与体基を含む利尿化合物、組成物および使用方法 |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
ES2382009T3 (es) | 2006-12-01 | 2012-06-04 | Bristol-Myers Squibb Company | Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares |
FR2924713B1 (fr) * | 2007-12-11 | 2010-01-29 | Servier Lab | Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
EP2575808A1 (en) | 2010-05-28 | 2013-04-10 | Mahmut Bilgic | Combination of antihypertensive agents |
CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
TW202314018A (zh) * | 2021-06-21 | 2023-04-01 | 荷蘭商Asm Ip私人控股有限公司 | 用於形成包含氧化銦鎵鋅的層之反應器系統及方法 |
WO2023001880A1 (en) | 2021-07-22 | 2023-01-26 | Krka, D. D., Novo Mesto | Bilayer tablet comprising telmisartan and indapamide |
EP4295839A1 (en) | 2022-06-20 | 2023-12-27 | KRKA, d.d., Novo mesto | Combination of valsartan and indapamide |
EP4374855A1 (en) | 2022-11-22 | 2024-05-29 | KRKA, D.D., Novo Mesto | Pharmaceutical dosage form of candesartan and indapamide |
-
1968
- 1968-03-06 GB GB00906/68A patent/GB1203691A/en not_active Expired
-
1969
- 1969-02-14 NO NO00613/69A patent/NO128068B/no unknown
- 1969-02-19 BE BE728658D patent/BE728658A/xx not_active IP Right Cessation
- 1969-02-24 DE DE19691909180 patent/DE1909180A1/de active Pending
- 1969-02-25 US US802208A patent/US3565911A/en not_active Expired - Lifetime
- 1969-02-26 DK DK106769AA patent/DK126193B/da unknown
- 1969-03-03 SE SE02903/69A patent/SE334887B/xx unknown
- 1969-03-05 ES ES364421A patent/ES364421A1/es not_active Expired
- 1969-03-05 FR FR6906023A patent/FR2003311A1/fr active Pending
- 1969-03-05 CH CH334269A patent/CH507940A/fr not_active IP Right Cessation
- 1969-03-05 NL NL696903421A patent/NL145226B/xx not_active IP Right Cessation
- 1969-03-05 FI FI690659A patent/FI50119C/fi active
-
1980
- 1980-07-09 IT IT8049196A patent/IT8049196A0/it unknown
Also Published As
Publication number | Publication date |
---|---|
CH507940A (fr) | 1971-05-31 |
IT8049196A0 (it) | 1980-07-09 |
DK126193B (da) | 1973-06-18 |
NO128068B (e) | 1973-09-24 |
US3565911A (en) | 1971-02-23 |
GB1203691A (en) | 1970-09-03 |
FI50119C (fi) | 1975-12-10 |
DE1909180A1 (de) | 1970-07-02 |
SE334887B (e) | 1971-05-10 |
FI50119B (e) | 1975-09-01 |
NL145226B (nl) | 1975-03-17 |
ES364421A1 (es) | 1971-02-01 |
FR2003311A1 (e) | 1969-11-07 |
NL6903421A (e) | 1969-09-09 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: SOC FRANCAISE DE RECHERCHE MEDICALE Effective date: 19890219 Owner name: SCIENCE UNION & CIE Effective date: 19890219 |